Microbial drug resistance
A team of researchers from the University of Lyon has sounded the alarm on the growing concern of antibiotic resistance, warning that it is projected to become the leading cause of mortality worldwide by 2050. The University of Lyon's research, published in the Archives of Microbiology, emphasizes the
International cooperation
A new study led by Peter Sogaard Jorgensen from the Stockholm Resilience Centre at Stockholm University reveals that countries can reduce antibiotic resistance through effective domestic interventions, contrary to the prevailing notion that it is an "inevitable catastrophe beyond our control." The study assessed the level of government
Infection
Public health in Rwanda is facing a critical threat from antimicrobial resistance (AMR), a natural process accelerated by human activity, mainly the misuse and overuse of antimicrobials. In 2019, an estimated 2,400 deaths were directly linked to drug-resistant infections, and another 9,800 were associated with them. The World
Microbial drug resistance
Antimicrobial resistance (AMR) has become a pressing concern in hospitals and communities worldwide, putting millions of lives at risk. Medical experts warn that antibiotics, once effective in treating serious infections, are now failing, leading to increased mortality rates and prolonged and costly treatments for those who survive. According to doctors,
Microbial drug resistance
As the world prepares for the 79th session of the United Nations General Assembly (UNGA79), the World Health Organization (WHO) and partners are calling on world leaders to take decisive action to address critical global health challenges, particularly the growing threat of antimicrobial resistance (AMR). Without immediate action, AMR could
Microbial drug resistance
As the world continues to recover from the COVID-19 pandemic and accelerate efforts to meet the 2030 Sustainable Development Goals (SDGs), the World Health Organization (WHO) has sounded a stark warning about the threat of antimicrobial resistance (AMR). AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to
Microbial drug resistance
The World Health Organization (WHO) and partners will hold a series of high-level meetings throughout the 79th session of the United Nations General Assembly (UNGA79) from 20 to 30 September 2024, to address critical global health challenges and invest in global public health. The second High-Level Meeting on Antimicrobial Resistance
Microbial drug resistance
The World Health Organization (WHO) has identified 40 research priorities to address antimicrobial resistance (AMR) in human health by the year 2030. These priorities focus on bacterial and fungal pathogens causing tuberculosis and other critical diseases. The research agenda aims to encourage investment in generating evidence to understand AMR dynamics
